AegirBio AB calls for payment of Tranche 1 of SEK 7.50 million and intends to carry out a directed set-off issue of 5,175,374 shares to Atlas Special Opportunities, LLC
On April 9, 2024, AegirBio AB ("AegirBio" or the "Company") announced that the Company had entered into a conditional loan facility agreement with Atlas Special Opportunities, LLC ("Atlas") under which the Company can call for loans in seven (7) tranches (hereinafter "Tranches" or each a "Tranche") in an aggregate nominal amount of SEK 45.00 million before deduction of set-up fee (the "Loan Facility") and transaction costs. The entering into of the Loan Facility has been conditional upon the completion of the amendments to the agreement for outstanding convertible bonds of series 2023/2025 (